Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR001450)
National Institute on Drug Abuse (DA0036566)
Received: 1 December 2021
Accepted: 23 March 2022
First Online: 5 April 2022
: Deemed not human research and given exempt approval by the local IRB.
: None of the funding agencies had any role in the preparation, approval, or decision to submit the manuscript for publication.
: The authors declare that they have no competing interests.